// App-Quantinova.ai

2254 : Variations in the epithelial-mesenchymal transition (EMT) program by non-small cell lung cancer (NSCLC) circulating tumor cells (CTCs) do not influence survival

Researchers

Presenter

  • Colin R. Lindsay

Principal Investigators

  • Vincent Faugeroux

  • Emma Pailler

  • Maria-Virginia Bluthgen

  • Chloe Pannet

  • Maud Ngo-Camus

  • Guillaume Bescher

  • Fanny Billiot

  • Jordi Remon

  • Philippe Vielh

  • David Planchard

  • Jean-Charles Soria

  • Benjamin Besse

  • Francoise Farace

Medical Centers

  • Institut Gustave-Roussy, Villejuif, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating tumor cells

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved